Impact of 45S5-Bioactive Glass on Chondrocytes in Knee Osteoarthritis—In Vitro Study Exploring Cellular Responses
Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1-a marker of chondrocyte hypertrophy-was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.
Authors
- Fabian Westhauser (ORCID: https://orcid.org/0000-0001-9948-4209)
- Tobias Renkawitz
- Simone Gantz
- Elena Tripel
- Babak Moradi (ORCID: https://orcid.org/0000-0003-1714-2171)
- Aldo Roberto Boccaccini (ORCID: https://orcid.org/0000-0002-7377-2955)
- Jörg Fellenberg (ORCID: https://orcid.org/0000-0002-6187-6474)
- M. Marinescu (ORCID: https://orcid.org/0009-0009-0997-8367)
- Sebastién Hagmann (ORCID: https://orcid.org/0000-0003-1671-2494)
- Hadrian Platzer (ORCID: https://orcid.org/0000-0001-9805-3810)
- Ravikumar Mayakrishnan
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Hochschule für Angewandte Wissenschaften Kiel (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital Schleswig-Holstein (DE)
- Asklepios Kliniken Bad Abbach (DE)
- Clinical Research Center Kiel (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Journal of Functional Biomaterials
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3390/jfb16090339
- Citations
- 2
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.34